Korean Journal of Microbiology (미생물학회지)

The Microbiological Society of Korea (한국미생물학회)
권호 표지

Expression of Human p53 Gene as Glutathione S-transferase Fusion Proteins in Escherichia coli

사람의 p53 유전자와 Glutathione S-Transferase와의 융합 단백질의 대장균에서의 발현

  • 오상진 (전남대학교 자연과학대학 미생물학과)
  • Published : 1993.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

Alterations of the p53 gene arc among the most frequent genetic changes in human cancer and often result in increased levels of p53 protein within the malignant cells. Detection of accumulated p53 protein can be a useful prognostic tool in human cancer. In order to make polyclonal antibodies for immunohistochemical screening. human p53 gene was expressed in E. coli in the form of GST (glutathione S-transfi.:rase) fusion proteins. Two p53 gene fragments. which were N('()I small fragment encoding amino acid residues of 1-151-: and Ncol large fragment of 159-393. were subeloned into the unique BamHI site present within the pGEX-2T vector using BamHI linker and recombinant plasmids pGTNS and pGTNL were constructed. respectively. The p53 cDNA fragment (from pC53-$SN_3$,) encoding amino acid 38-145 (proline at residue 72) was amplified by polymerase chain reaction(PCR). The amplified DNA was digested with BamHI and Prull and inserted into the BamHI-Smal sites of pG EX-2T and recombinant plasmid pGTBP was constructed. After IPTG induction of these plasmids for 4 hours. fusion proteins were purified from E. coli extracts with glutathione Sepharose beads. The bound proteins were resolved by 10% SDS-polyacrylamide gel electrophoresis and the molecular weights were 54 kDa. 53 kDa and 40 kDa. respectively. Approximately one milligram of fusion proteins were purified from 1 -liter cultures.

p53 유전자의 변화는 인간의 여러 암에서 가장 흔하게 발견되며 종양세포내에서는 이러한 변형된 p53 단백질의 양의 증가가 초래된다. 세포내에 축적된 p53 단백질의 발견은 인간의 암증세를 판단할 유용한 기중이 되기도 한다. 본 연구에서는 이러한 면역조직화학 검사에 쓰일 수 있는 폴리클로날 항체를 만들기 위햐여 사람의 p53 유전자를 glutathione S-transferase 와의 융합 단백질의 형태로서 대장균내에서 발현시켰다. p53 의 아미노산 1-158번을 코딩하고 있는 NeoI fragment 와 아미노산 159-393 번을 코딩하는 NocI-BamHI fragment 를 BamHI linker 를 이용하여 in frame 으로 pGEX-2T 의 BamHI 자리에 삽입하여 재조합 플라스미드 pGTNS 와 pGTNL 을 각각 만들었다. 또 PCR 에 의한 증폭에 의햐여 아미노산 38-145번을 코딩하는 유전자 부위를 증폭하였으며 BamHI 과 PvuII 로 절단하여 pGEX-2T의 BamHI 과 SmaI 자리에 삽입함으로써 pGTBP 를 제조하였다. 이들 재조합 균주들을 IPTG 로 4시간 induction 한 후 세포 추출물로부터 glutathione Sepharose bead 를 이용하여 융합단백질을 분리하였다. Bead 에 결합된 단백질은 10% SDS-polyacrylamide gel 에서 전기영동하였으며, 각각의 분자량은 54 kDa, 53 kDa 와 40 kDa 였다. 이러한 방법으로 1리터 배양으로부터 약 1mg 의 단백질을 정제하였다.

Keywords

References

  1. Science v.249 Suppression of human colorectal carcinoma cell growth by wildtype p53 Baker,S.J.;S.Markowitz;E.R.Fearon;J.K.U.Wilson;B.Vogelstein
  2. Oncogene v.6 Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies Bartek,J.;J.Bartkova;B.Bojtesek;Z.Staskova;J.Lukas;A.Rejthar;J.Kovarik;C.A.Midgley;J.B.Gannon;D.P.Lane
  3. Nature v.350 Selective G to T mutation of p53 gene in hepatocellular carcinoma from suthern Africa Bressac,B.;M.Kew;J.Wands;M.Osturk
  4. Int. J. Cancer v.39 Presence of circulating antibodies against cellular protein p53 in a natable proportion of children with B-cell lymphoma Caron de Fromentel,C.;L.F.May;H.Mouriesse;J.Lemerle;K.Chandrasekaran;P.May
  5. Science v.250 Genetic mechanisms of tumor suppression by the human p53 gene Chen,P.L.;Y.Chen;R.Brookstein;W.H.Lee
  6. Mol. Cell. Biol. v.8 Purification of complexes of nuclear oncogene p53 with rat and Escherichia coli beat shock proteins: in vitro dissociation of hsc70 and dnaK from murine p53 by ATP Clarke,C.F.;K.Cheng;A.B.Frey;R.Stein;P.W.Hinds;A.J.Levin
  7. Int. J. Cancer v.30 Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer Crawford,L.V.;D.C.Pim;R.D.Bullbrook
  8. J. Clin. Lab. Anal. v.3 Competitive ELISA for detection of native ras gene-related products in sera of cancer patients Epelbaum,R.;A.H.Bartal;M.Rivkin;N.Tugendhaft;C.Shalitin
  9. Science v.249 Presence of a potent transcription activating sequence in the p53 protein Fields,S.;S.K.Jang
  10. Mol. Cell. Biol. v.8 Activating mutations for transformation by p53 produce a gene product that forms and hsc7-p53 complex with an altered half-life Finlay,C.A.;P.W.Hinds;T.Tan;D.Eliyahu;M.Oren;A.J.Levine
  11. Cell v.57 The p53 protooncogene can act as a suppressor of transformation Finlay,C.;P.Hinds;A.J.Levine
  12. EMBO J. v.9 Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form Gannon,J.V.;R.Greaves;R.Iggo;D.P.Lane
  13. J. Virol. v.63 Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation Hinds,P.;C.Finlay;A.J.Levins
  14. Science v.253 -53 mutation in human cancers Hollstein,M.;D.Sidransky;B.Vogelstein;C.Harris
  15. Nature v.350 Mutational host spot in the p53 gene in human hepatocellular carcinomas Hsu,I.;R.Metcalf;T.Sun;J.Welsh;N.Wang;C.Harris
  16. Methods Enzymol. v.91 Isolation of microgram quantities of protein from polyacrylamide gels for amino acid sequence analysis Hunkapillar,M.W.;E.Lujan;F.Ostrander;L.E.Hood
  17. The p53 protooncogene and its product Common mechanisms of transformation by SV40, polyoma and papilloma viruses Levine,A.J.;C.Finlay;P.W.Hinds
  18. Nature v.351 The p53 tumour suppressor gene Levine,A.J.;J.Momand;C.A.Finlay
  19. Gene and Develop. v.5 Cellular location and cell cycle regulation by a temperature-sensitive p53 protein Martinez,J.;I.Georgoff;J.Martinez;A.J.Levine
  20. Cell v.62 Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 Michalovitz,D.;O.Halvey;M.Oren
  21. EMBO J. v.9 p53 is associated with p34ede2 in transformed cells Milner,J.;A.Cook;J.Mason
  22. Nature v.342 Mutations in the p53 gene occur in diverse human tumour types Nigro,J.;S.Baker;A.Preisinger;J.Jessup;R.Hostetter;K.Cleary;S.Bigner;N.Davidson;S.Baylin;P.Devilee;T.Glover;F.Collins;A.Weston;R.Modali;C.Harris;B.Vogelstein
  23. Science v.249 Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncohene Raycroft,L.;H.Wu;G.Lozano
  24. Cancer Res. v.52 The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot Schlichtholz,B.;Y.Legros;D.Gillet;C.Gaillard;M.Marty;D.Lane;F.Calvo;T.Soussi
  25. Gene v.67 Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase Smith,D.B.;K.S.Johnson
  26. Oncogene v.5 Structural aspects of the p53 protein in relation to gene evolution Soussi,T.;C.Caron de Fromentel;P.May
  27. Oncogene v.5 p53 interacts with p34ede2 in mammalian cells: implications for cell cycle control and oncogenesis Sturzbecher,H.W.;T.Maimets;P.Chumakov;R.Brain;C.Addison;V.Simanis;K.Rudge;R.Philip;M.Grimaldi;W.Court;J.R.Jenkins
  28. Science v.246 p53: a frequent target for genetic abnormalities in lung cancer Takahashi,T.;M.Nau;I.Chiba;M.J.Birrer;R.K.Rosenberg;M.Vinocour;M.Levitt;H.Pass;A.F.Gazdar;J.D.Minna
  29. EMBO J. v.4 Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells Zahut-Houri,R.;B.Bienz-Tadmor;D.Givol;M.Oren